Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Florida
About this trial
The purpose of this study is to look at how Alpha-1-antitrypsin (AAT) deficiency and Cystic Fibrosis (CF) affect white blood cells in the lungs, called macrophages, and their ability to work.
Eligibility criteria
Qualifiers
Signed informed consent
Male or female 18 years of age or older
Negative pregnancy test for women of childbearing potential
Hemoglobin >12.5 g/dl measured on the day of participation
Disqualifiers
Pregnancy or breastfeeding
Weight < 50 kg
History of anemia requiring blood transfusions, erythropoietin supplementation, or iron supplementation within the past 36 months
Known hemoglobin <12.5 g/dl within the past 90 days
Trial design
Treatments tested in this trial
- History and physical exam.
- Blood draw.
- Pulmonary function testing.
- Albuterol inhaler.
Treatment groups
220 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov